基于GEM模型的云南省生物医药产业集群竞争力研究

发布时间：2018-05-31 07:52

本文选题：产业集群竞争力 + 生物医药产业集群　；参考：《云南财经大学》2013年硕士论文

【摘要】：生物医药产业作为典型的高新技术产业，已经成为世界经济上发展最快的产业之一。生物医药产业自身对知识和技术有强烈的需求，尤其是技术创新、药品研发等过程更依赖于与相关企业和机构的合作，这就导致了生物医药产业具有明显的地理集聚的区位特征，更适合以产业集群的形式来发展。在美国、日本等国家都有以生物医药为核心的产业集群，并在国际市场上显示出很强的竞争力。这些成功的范例表明，形成生物医药产业集群会比独立的生物医药企业更具有竞争优势。我国人口众多，随着人民生活水平的提高和药品消费结构的变化，，生物医药产业在国民经济中的地位不断提高，并日益得到重视。我国早在1983年就成立了“中国生物技术发展中心”，并逐步将生物医药产业作为国民经济中一个战略性产业进行规划和部署。通过国家政策的引导和国外成功经验的借鉴，我国上海、吉林、石家庄等地形成了一些有代表性的生物医药产业集群。云南省具有得天独厚的地理和自然环境，特有的丰富资源为生物医药产业的发展提供了物质基础。由于自身环境的优势和该产业巨大的发展潜力，云南省委、省政府提出将生物医药产业打造成的带动本省经济发展的支柱产业之一。这也就要求更加重视产业集群的带动作用，结合自身发展情况对生物医药产业集群竞争力进行更深入的分析研究。本文首先通过阅读相关文献资料，梳理了国内外关于产业集群竞争力研究的进展和成果；然后对产业集群竞争力评价的GEM模型进行了详细的介绍，并指出该模型在定量评价集群竞争力方面的优势；接着以GEM模型为基础，构建生物医药产业集群竞争力评价指标体系，利用因子分析法确定各个指标的权重，再结合企业问卷调查，得出云南省生物医药产业集群的竞争力的GEM模型得分；最后根据得分情况进行进一步的分析，找出影响云南生物医药产业集群竞争力的制约因素，提出有针对性的建议以提升竞争力水平。
[Abstract]:As a typical high-tech industry, biomedical industry has become one of the fastest-growing industries in the world economy. The biomedical industry itself has a strong demand for knowledge and technology, especially technological innovation, drug development and other processes more dependent on cooperation with relevant enterprises and institutions. This leads to the obvious geographical agglomeration of the biomedical industry, which is more suitable for the development of industrial clusters. In the United States, Japan and other countries have biomedicine as the core of the industrial clusters, and in the international market has shown a strong competitiveness. These successful examples show that the formation of a biomedical industry cluster will be more competitive than independent biomedical enterprises. With the improvement of people's living standard and the change of drug consumption structure, the status of biomedical industry in the national economy has been improved and paid more and more attention. As early as 1983, China established the China Biotechnology Development Center, and gradually planned and deployed the biomedical industry as a strategic industry in the national economy. Through the guidance of national policy and the successful experience of foreign countries, some representative biomedical industry clusters have been formed in Shanghai, Jilin and Shijiazhuang. Yunnan Province has a unique geographical and natural environment, and its unique rich resources provide the material basis for the development of biomedical industry. Because of the advantages of its own environment and the huge development potential of this industry, Yunnan Provincial Committee and the provincial government proposed to build the biomedical industry into one of the pillar industries to promote the economic development of the province. Therefore, more attention should be paid to the leading role of industrial clusters, and the competitiveness of biomedical industrial clusters should be further analyzed and studied in the light of their own development. In this paper, first of all, by reading the relevant literature, the paper reviews the progress and achievements of the research on the competitiveness of industrial clusters at home and abroad, and then introduces the GEM model of the competitiveness evaluation of industrial clusters in detail. It also points out the advantages of the model in quantitatively evaluating the competitiveness of the cluster, and then, based on the GEM model, constructs the evaluation index system of the competitiveness of the biomedical industry cluster, and determines the weight of each index by using the factor analysis method. Combined with the questionnaire survey of enterprises, the GEM model score of the competitiveness of Yunnan biomedical industry cluster is obtained. Finally, according to the score, further analysis is made to find out the restrictive factors that affect the competitiveness of Yunnan biomedical industry cluster. Put forward targeted suggestions to improve competitiveness.
【学位授予单位】：云南财经大学
【学位级别】：硕士
【学位授予年份】：2013
【分类号】：F426.72

【参考文献】